Therapeutics & Medical Devices
Total Trials
12
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,550
NCT03232710
Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition
Phase: N/A
Role: Lead Sponsor
Start: Jun 26, 2017
Completion: Jun 30, 2018
NCT03258242
A Study of Keluo Xin Capsule Compare to Placebo in Terms of Efficacy and Safety in Patients With Diabetic Retinopathy
Phase: Phase 2
Start: Aug 31, 2017
Completion: Feb 28, 2020
NCT06393803
Phase 1 Study of KH607 Tablets
Phase: Phase 1
Start: Oct 21, 2023
Completion: Oct 30, 2024
NCT06534320
Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of DA-302168S Tablets
Start: Apr 18, 2024
Completion: Dec 31, 2024
NCT06534346
The Food Effect on Pharmacokinetics of DA-302168S
Start: Jul 18, 2024
Completion: Aug 3, 2024
NCT06541730
A Study Evulating DA-302168S Tablets in Overweight/Obese Subjects
Start: Aug 30, 2024
Completion: Jan 30, 2025
NCT06589817
A Double-Blind, Randomized Comparative Study of Carliprazine and Aripiprazole in Patients with Acute Schizophrenia
Phase: Phase 3
Start: Oct 31, 2024
Completion: Dec 31, 2026
NCT06822946
Zhibitai Capsules for the Treatment of Primary Hyperlipidemia
Start: Feb 14, 2025
Completion: Apr 30, 2026
NCT06953063
A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Overweight/Obese Subjects
Start: May 15, 2025
Completion: Dec 31, 2025
NCT07044960
A Phase 1 Study of KHN702 Tablets in Healthy Subjects
Start: Jun 21, 2025
Completion: Apr 1, 2026
NCT07096791
A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum Depression
Start: Jul 31, 2025
Completion: Apr 30, 2027
NCT07101120
A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Adult Participents With Major Depressive Disorder
Start: Aug 31, 2025
Loading map...